BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study
There is little information on BNT162b2 vaccine-induced variant-specific immunogenicity, safety data and dynamics of breakthrough infections in pediatric populations. We addressed these questions using a prospective two dose BNT162b2 (10 mcg) vaccination cohort study of healthy children 5-11 years i...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
其他作者: | |
格式: | Article |
語言: | English |
出版: |
2024
|
主題: | |
在線閱讀: | https://hdl.handle.net/10356/173890 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|